Advances in the development of molecular genetic tools for Mycobacterium tuberculosis-Reference-Cited by-同舟云学术

Advances in the development of molecular genetic tools for Mycobacterium tuberculosis

Published:2018-06 Issue:6 Volume:45 Page:281-297
ISSN:1673-8527
Container-title:Journal of Genetics and Genomics
language:en
Short-container-title:Journal of Genetics and Genomics

Author:

Chhotaray Chiranjibi,Tan Yaoju,Mugweru Julius,Islam Md Mahmudul,Adnan Hameed H.M.,Wang Shuai,Lu Zhili,Wang Changwei,Li Xinjie,Tan Shouyong,Liu Jianxiong,Zhang Tianyu^ORCID

Funder

National Mega-project of China for Innovative Drugs

National Natural Science Foundation of China

Chinese Academy of Sciences

Public Research and Capacity Building Project of Guangdong Province

Guangzhou Municipal Industry and Research Collaborative Innovation Program

Key Project

Science and Technology Innovation Leader of Guangdong Province

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology

Reference267 articles.

1. Pathway-selective sensitization of Mycobacterium tuberculosis for target-based whole-cell screening;Abrahams;Chem. Biol.,2012

2. Conditional silencing of topoisomerase I gene of Mycobacterium tuberculosis validates its essentiality for cell survival;Ahmed;FEMS Microbiol. Lett.,2014

3. Rapid indication of multidrug-resistant tuberculosis from liquid cultures using FASTPlaqueTB-RIF™, a manual phage-based test;Albert;Int. J. Tubercul. Lung Dis.,2002

4. Usefulness of a new mycobacteriophage-based technique for rapid diagnosis of pulmonary tuberculosis;Alcaide;J. Clin. Microbiol.,2003

5. Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines;Aldovini;Nature,1991

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mycobacterial Genetic Technologies for Probing the Host-Pathogen Microenvironment;Infection and Immunity;2023-06-15

2. Low-cost anti-mycobacterial drug discovery using engineered E. coli;Nature Communications;2022-07-07

3. Synthesis, molecular docking, and biological evaluation of novel 1,2,4‐triazole‐isatin derivatives as potential Mycobacterium tuberculosis shikimate kinase inhibitors;Chemical Biology & Drug Design;2022-06-06

4. Programmable Base Editing in Mycobacterium tuberculosis Using an Engineered CRISPR RNA-Guided Cytidine Deaminase;Frontiers in Genome Editing;2021-12-08

5. CRISPR/Cas genome editing: A frontier for transforming precision cassava breeding;African Journal of Biotechnology;2021-06-30